Skip to main content
14 December 2019
Last updated:
Friday 13 December 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Roche to acquire Promedior

Sunday 17 November 2019
Country

Switzerland

The Roche group has staked out fibrotic disease as a growth area with the planned acquisition of Promedior Inc of Lexington, Massachusetts, US for up to $1.39 billion.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Company News
Finance, Grants, Deals

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Jacques Biton joins supervisory board at Nosopharm
Sunday December 8 2019
Norman Baylor joins science board at Valneva
Sunday December 8 2019
Vectura appoints Will Downie as CEO
Sunday December 8 2019
Santhera appoints Dario Eklund as CEO
Sunday December 8 2019
Robin Bhattacherjee is new CEO at Actimed
Sunday December 8 2019

© 2019 Evernow Publishing Ltd. Powered by Drupal.